Q3 profit after tax rises 54%; Sanofi declares Rs 75 interim dividend

Pat Growth 25pctRevenue DeclineEbitda Margin ExpansionExceptional ItemResults View source PDF Explain this filing

SANOFI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.4%Reaction day

₹3203.00

prior close

₹3265.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending

Pharmaceuticals peers, median of 173sector-0.8%+0.4% vs sector

On the reaction day the stock moved 0.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+4.5

10m

+2.3

15m

+2.1

30m

+1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.4pendingpending-0.8+0.4

Next day

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q3 revenue rose 3.4% to Rs 4,917 million and profit after tax rose 54% to Rs 1,167 million. Profit before tax and exceptional items rose 22% to Rs 1,577 million; margin improved to 34% from 29%. Q3 2025 had a Rs 273 million separation cost. Nine-month revenue dipped 1.1%, while profit rose 14%. Interim dividend: Rs 75 per share.

Likely market impact

Profit growth and dividend support shareholders, though nine-month revenue dipped slightly and the prior-year cost comparison aided profit.